Age-related macular degeneration market expected to grow to $22.8bn in 2031
The AMD market is projected to grow strongly over the next nine years, but there are potential barriers to this…
By
The AMD market is projected to grow strongly over the next nine years, but there are potential barriers to this…
ByA special purpose acquisition company (SPAC) focused on CDMOs has launched even as fundraising shell companies lose traction.
ByGlobal legal cannabis sales in 2020 were up by 45% on 2019, with several leading companies reporting triple-digit revenue growth.
ByMovfor is the first branded Molnupiravir variant that received EUA from BPOM RI in Indonesia.
It is unlikely that a new treatment class will overtake prostaglandin analogues as a first-line glaucoma treatment until 2030.
ByThere is a need for greater endometriosis awareness across the market, with the development of non-invasive diagnosis and more efficient…
ByThe UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK…
ByIntegra Therapeutics’ CEO discusses how the company’s gene writing tool could improve advanced therapies for patients.
ByThank you for subscribing to Pharmaceutical Technology